ArticleAdvanced biomedical research2026
Protecting Effects of Rutin and N-Acetyl Cysteine on PON1 Enzyme in Cyclosporine A-Treated Rats: An
Article in Advanced biomedical research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Paraoxonase 1 (PON1) is a potent antioxidant enzyme in serum that protects against the oxidation of low-density lipoprotein. This study investigated the effect of N-acetylcysteine (NAC), a synthetic precursor to the natural antioxidant glutathione, and Rutin, a natural antioxidant, on protecting PON1 enzyme activity in rats treated with cyclosporine A (CsA) using experimental and molecular dynamics simulation studies. Materials and Methods: In this study, 48 male rats were divided into six groups, each consisting of eight rats. Groups I, II, and III were CsA-free, while groups IV, V, and VI received 25 mg/kg CsA. Groups V and VI received daily NAC and Rutin (100 mg/kg) via intragastric gavage. After 21 days of treatment, all rats were euthanized, and the high-density lipoprotein parameter was measured using an auto analyzer in serum samples. PON1 enzyme activity was determined by its arylesterase property in serum samples. Docking and molecular dynamics simulation studies were performed using AutoDock V.4.2 and GROMACS 2022 software. Results: CsA decreased the PON1 enzyme arylesterase activity, while this activity increased in the groups that received CsA and Rutin, and/or CsA and NAC. The simulation results showed that all three compounds could bind into the PON1 independently and moderate its activity. Though serum PON1 arylesterase activity decreases in CsA received group, the combination of NAC or Rutin has a synergistic effect in further boosting PON1 aryl esterase enzyme activity when CsA is administered. Conclusion: The present findings indicate that NAC and Rutin have protective effects on the PON1 enzyme in CsA-treated adult rats.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.